Semaglutide (Ozempic, Wegovy, Rybelsus) Strengths: Strong evidence base with extensive clinical trial data Once-weekly dosing (injection) or daily (oral) Excellent glucose control and weight loss Proven cardiovascular and kidney benefits Widely available Considerations: Gastrointestinal side effects common initially Cost without insurance is significant Best for: Most patients seeking strong glucose control with weight loss
However, it's important to note that individual results may vary, and these injections are not a standalone solution for significant, long-term weight loss
But you should: What Happens Next
Bioengineered 13, 44934516
Due to Ozempic's extended half-life of approximately one week, overdose effects may persist for several days
It has also been found to be capable of mitigating some of the effects arising from haemotoxic snake poison when given in the acute phase of envenomation